Page 108 - Read Online
P. 108

Xu et al. J Transl Genet Genom 2021;5:218-39  https://dx.doi.org/10.20517/jtgg.2021.20  Page 238

                    DOI  PubMed
               159.      Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood 2003;102:2321-33.  DOI
                    PubMed
               160.      Bateman CM, Colman SM, Chaplin T, et al. Acquisition of genome-wide copy number alterations in monozygotic twins with acute
                    lymphoblastic leukemia. Blood 2010;115:3553-8.  DOI  PubMed
               161.      Torow N, Hornef MW. The neonatal window of opportunity: setting the stage for life-long host-microbial interaction and immune
                    homeostasis. J Immunol 2017;198:557-63.  DOI  PubMed
               162.      Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science
                    2012;336:489-93.  DOI  PubMed  PMC
               163.      Biesbroek G, Tsivtsivadze E, Sanders EA, et al. Early respiratory microbiota composition determines bacterial succession patterns
                    and respiratory health in children. Am J Respir Crit Care Med 2014;190:1283-92.  DOI  PubMed
               164.      Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and
                    childhood acute lymphoblastic leukaemia. Int J Epidemiol 2010;39:718-32.  DOI  PubMed  PMC
               165.      Ma X, Buffler PA, Wiemels JL, et al. Ethnic difference in daycare attendance, early infections, and risk of childhood acute
                    lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2005;14:1928-34.  DOI  PubMed
               166.      Urayama KY, Ma X, Selvin S, et al. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J
                    Cancer 2011;128:1632-43.  DOI  PubMed  PMC
               167.      Von Behren J, Spector LG, Mueller BA, et al. Birth order and risk of childhood cancer: a pooled analysis from five US States. Int J
                    Cancer 2011;128:2709-16.  DOI  PubMed  PMC
               168.      Marcotte EL, Ritz B, Cockburn M, Yu F, Heck JE. Exposure to infections and risk of leukemia in young children. Cancer Epidemiol
                    Biomarkers Prev 2014;23:1195-203.  DOI  PubMed  PMC
               169.      Marcotte EL, Thomopoulos TP, Infante-rivard C, et al. Caesarean delivery and risk of childhood leukaemia: a pooled analysis from
                    the Childhood Leukemia International Consortium (CLIC). Lancet Haematol 2016;3:e176-85.  DOI  PubMed  PMC
               170.      Francis SS, Wallace AD, Wendt GA, et al. In utero cytomegalovirus infection and development of childhood acute lymphoblastic
                    leukemia. Blood 2017;129:1680-4.  DOI  PubMed  PMC
               171.      Francis SS, Selvin S, Metayer C, et al. Mode of delivery and risk of childhood leukemia. Cancer Epidemiol Biomarkers Prev
                    2014;23:876-81.  DOI  PubMed
               172.      Wang L, Gomez SL, Yasui Y. Racial and ethnic differences in socioeconomic position and risk of childhood acute lymphoblastic
                    leukemia. Am J Epidemiol 2017;185:1263-71.  DOI  PubMed
               173.      Bona K, Blonquist TM, Neuberg DS, Silverman LB, Wolfe J. Impact of socioeconomic status on timing of relapse and overall
                    survival for children treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). Pediatr Blood Cancer
                    2016;63:1012-8.  DOI  PubMed
               174.      Acharya S, Hsieh S, Shinohara ET, DeWees T, Frangoul H, Perkins SM. Effects of race/ethnicity and socioeconomic status on
                    outcome in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2016;38:350-4.  DOI  PubMed
               175.      Kehm RD, Spector LG, Poynter JN, Vock DM, Altekruse SF, Osypuk TL. Does socioeconomic status account for racial and ethnic
                    disparities in childhood cancer survival? Cancer 2018;124:4090-7.  DOI  PubMed  PMC
               176.      Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with
                    acute lymphoblastic leukemia. Blood 2002;100:1957-64.  DOI  PubMed
               177.      Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic
                    white children with acute lymphoblastic leukemia: a report from the children's oncology group. J Clin Oncol 2012;30:2094-101.  DOI
                    PubMed  PMC
               178.      Rosenberg AR, Kroon L, Chen L, Li CI, Jones B. Insurance status and risk of cancer mortality among adolescents and young adults.
                    Cancer 2015;121:1279-86.  DOI  PubMed  PMC
               179.      Krakora R, Shih W, Popli P, et al. Impact of insurance status on survival outcomes in adults with acute lymphoblastic leukemia
                    (ALL): a single-center experience. Clin Lymphoma Myeloma Leuk 2020;20:e890-6.  DOI  PubMed
               180.      Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage
                    at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 2008;9:222-31.  DOI  PubMed
               181.      Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults
                    with cancer. J Clin Oncol 2010;28:4800-9.  DOI  PubMed
               182.      Schmiegelow K, Heyman M, Gustafsson G, et al; Nordic Society of Paediatric Haematology and Oncology (NOPHO). The degree of
                    myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts
                    risk of relapse. Leukemia 2010;24:715-20.  DOI  PubMed
               183.      Landier W, Hughes CB, Calvillo ER, et al. A grounded theory of the process of adherence to oral chemotherapy in Hispanic and
                    caucasian children and adolescents with acute lymphoblastic leukemia. J Pediatr Oncol Nurs 2011;28:203-23.  DOI  PubMed  PMC
               184.      Koren G, Ferrazini G, Sulh H, et al. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in
                    children. N Engl J Med 1990;323:17-21.  DOI  PubMed
               185.      Bhatia S, Landier W, Hageman L, et al. 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a
                    Children's Oncology Group study. Blood 2014;124:2345-53.  DOI  PubMed  PMC
               186.      Wu YP, Stenehjem DD, Linder LA, et al. Adherence to oral medications during maintenance therapy among children and adolescents
                    with acute lymphoblastic leukemia: a medication refill analysis. J Pediatr Oncol Nurs 2018;35:86-93.  DOI  PubMed  PMC
               187.      Rytting ME, Jabbour EJ, O'Brien SM, Kantarjian HM. Acute lymphoblastic leukemia in adolescents and young adults. Cancer
   103   104   105   106   107   108   109   110   111   112   113